November 14, 2012
Naoki Tani, president and CEO of RaQualia Pharma, explained amendments to the company’s midterm management plan for 2012-14 in a business briefing held on November 12 in Tokyo, and revealed that RaQualia positions the fields of digestive diseases and pain...read more